These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis. Ungprasert P; Upala S; Sanguankeo A; Warrington KJ Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748 [TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Ungprasert P; Sanguankeo A; Upala S; Knight EL Semin Arthritis Rheum; 2014 Dec; 44(3):366-70. PubMed ID: 25074657 [TBL] [Abstract][Full Text] [Related]
6. Smoking as a risk factor for giant cell arteritis: A systematic review and meta-analysis. Brennan DN; Ungprasert P; Warrington KJ; Koster MJ Semin Arthritis Rheum; 2018 Dec; 48(3):529-537. PubMed ID: 30093239 [TBL] [Abstract][Full Text] [Related]
7. Lower body mass index is associated with a higher risk of giant cell arteritis: a systematic review and meta-analysis. Ungprasert P; Thongprayoon C; Warrington KJ Ann Transl Med; 2015 Sep; 3(16):232. PubMed ID: 26539449 [TBL] [Abstract][Full Text] [Related]
9. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study. Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315 [TBL] [Abstract][Full Text] [Related]
10. Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis. Hill CL; Black RJ; Nossent JC; Ruediger C; Nguyen L; Ninan JV; Lester S Semin Arthritis Rheum; 2017 Feb; 46(4):513-519. PubMed ID: 28040246 [TBL] [Abstract][Full Text] [Related]
11. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: A meta-analysis of observational studies. Nsengiyumva V; Fernando ME; Moxon JV; Krishna SM; Pinchbeck J; Omer SM; Morris DR; Jones RE; Moran CS; Seto SW; Golledge J Atherosclerosis; 2015 Dec; 243(2):645-51. PubMed ID: 26554715 [TBL] [Abstract][Full Text] [Related]
12. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities. Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663 [TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis. Ungprasert P; Koster MJ; Thongprayoon C; Warrington KJ Clin Rheumatol; 2016 Nov; 35(11):2741-2747. PubMed ID: 27572522 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis. Alvarez-Rodriguez L; Muñoz Cacho P; Lopez-Hoyos M; Beares I; Mata C; Calvo-Alen J; Villa I; Martinez-Taboada VM Autoimmun Rev; 2011 Oct; 10(12):790-2. PubMed ID: 21726670 [TBL] [Abstract][Full Text] [Related]
15. Risk of incident atrial fibrillation in patients with rheumatoid arthritis: a systematic review and meta-analysis. Ungprasert P; Srivali N; Kittanamongkolchai W Int J Rheum Dis; 2017 Apr; 20(4):434-441. PubMed ID: 26692475 [TBL] [Abstract][Full Text] [Related]
16. Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis. Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR Semin Arthritis Rheum; 2017 Apr; 46(5):650-656. PubMed ID: 27839741 [TBL] [Abstract][Full Text] [Related]
17. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870 [TBL] [Abstract][Full Text] [Related]
18. Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population. Serrano A; Carmona FD; Miranda-Filloy JA; Castañeda S; Rodríguez-Rodríguez L; Morado IC; Gómez-Vaquero C; Solans R; Sopeña B; Blanco R; Unzurrunzaga A; Ortego-Centeno N; Marí-Alfonso B; de Miguel E; Hidalgo-Conde A; Martín J; González-Gay MA Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S29-33. PubMed ID: 22512842 [TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis and risk of venous thromboembolism: A systematic review and meta-analysis. Ungprasert P; Srivali N; Kittanamongkolchai W Mod Rheumatol; 2015 Nov; 25(6):893-897. PubMed ID: 25849852 [TBL] [Abstract][Full Text] [Related]
20. Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden. Ji J; Dimitrijevic I; Sundquist J; Sundquist K; Zöller B Scand J Rheumatol; 2017 Nov; 46(6):484-489. PubMed ID: 28276953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]